ENTRADA THERAPEUTICS, INC.

Profile

Company Names

ENTRADA THERAPEUTICS, INC.
CYCLOPORTERS, INC.

Addresses

6 TIDE STREET, BOSTON, MA 02210

50 NORTHERN AVENUE, BOSTON, MA 02210

C/O FOLEY HOAG LLP, 155 SEAPORT BLVD., BOSTON, MA 02210

28 STATE STREET, SUITE 2303, BOSTON, MA 02109

Phone Numbers

857-305-1825

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$150,871,750.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-03-29 
$116,249,999.00 
$116,249,999.00 
$0.00 
Equity 
2
2018-12-14 
$34,021,752.00 
$59,021,750.00 
$24,999,998.00 
Equity 
1
2016-10-27 
$599,999.00 
$1,599,998.00 
$999,999.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTINE 
 
BRENNAN 
DIRECTOR
ENTRADA THERAPEUTICS, INC.   |  TALLAC THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  REDONA THERAPEUTICS, INC.
JOHN 
 
CROWLEY 
DIRECTOR
WEATHER ANALYTICS, LLC   |  COTA, INC.   |  AMICUS THERAPEUTICS INC   |  MERUS N.V.   |  ENTRADA THERAPEUTICS, INC.
JOHN 
F. 
CROWLEY 
DIRECTOR
AMICUS THERAPEUTICS INC   |  ENTRADA THERAPEUTICS, INC.   |  AMICUS THERAPEUTICS, INC.
DIPAL 
 
DOSHI 
EXECUTIVE OFFICER, DIRECTOR
ENTRADA THERAPEUTICS, INC.
NATHAN 
 
DOWDEN 
EXECUTIVE OFFICER
ENTRADA THERAPEUTICS, INC.
TODD 
 
FOLEY 
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  ZALICUS INC.   |  CELLADON CORP   |  SELEXYS PHARMACEUTICALS CORP   |  PROTEON THERAPEUTICS INC   |  ICONIC THERAPEUTICS INC   |  VALERITAS INC   |  TETHEREX PHARMACEUTICALS CORP   |  CLINICAL INK, INC.   |  SEMMA THERAPEUTICS, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  MOAT BIOTECHNOLOGY CORP   |  CROSSBOW THERAPEUTICS, INC.   |  FIREFLY BIO, INC.   |  AKTIS ONCOLOGY, INC.
ANJA 
 
HARMEIER 
DIRECTOR
MACROLIDE PHARMACEUTICALS, INC.   |  ENTRADA THERAPEUTICS, INC.
PETER 
 
KIM 
DIRECTOR
SAM 3+4 JOINT VENTURE   |  DIGITAL313, INC.   |  CHILTON STRATEGIC EQUITIES, L.P.   |  CHILTON MID CAP CORE EQUITIES, L.P.   |  CHILTON GLOBAL CREDIT OPPORTUNITIES, L.P.   |  CHILTON CORE EQUITIES, L.P.   |  CHILTON DIVIDEND SHARES, L.P.   |  CTC ACCESS FUND, L.P.   |  CHILTON SELECT EQUITY FUND, L.P.   |  CURISIUM INC.   |  ACTIV SURGICAL, INC.   |  GRAPH BLOCKCHAIN INC   |  S4 CAPITAL PLC   |  CHILTON OPPORTUNITY TRUST, L.P.   |  CHILTON QP EUROPEAN PARTNERS, L.P.   |  CHILTON SMALL CAP + MID CAP PARTNERS, L.P.   |  CHILTON EUROPEAN INTERNATIONAL (BVI) LTD.   |  CHILTON ADVANTAGE FUND, L.P.   |  CHILTON INVESTMENT PARTNERS, L.P.   |  ENTRADA THERAPEUTICS, INC.   |  ASCENT ALTAMONTE, LLC   |  ASCENT CAF MULTIFAMILY FUND I, LLC   |  ASCENT CHISHOLM PARK, LLC   |  ASCENT DAKOTA RIDGE, LLC   |  SUNRISE ASCENT ON BETHANY PARTNERS, LLC   |  SUNRISE ASCENT ON ENCANTO PARTNERS, LLC   |  ASCENT EQUITY DEBT FUND I, LLC   |  ASCENT METROPARK, LLC   |  CHILTON PRIVATE EQUITY FUND, L.P.   |  ASCENT IN CHANDLER PARTNERS, LLC   |  ASCENT HR FRISCO, LLC   |  CHILTON TRUST ROYAL PALM EQUITY FUND, L.P.   |  CHILTON TRUST ROYAL PALM ABSOLUTE RETURN FUND, LP   |  CHILTON TRUST ROYAL PALM GROWTH FUND, LP
NERISSA 
 
KREHER 
EXECUTIVE OFFICER
ENTRADA THERAPEUTICS, INC.
CAROLE 
 
NUECHTERLEIN 
DIRECTOR
LYSOSOMAL THERAPEUTICS, INC.   |  CIVI BIOPHARMA HOLDINGS, INC.   |  MACULOGIX, INC.   |  ENTRADA THERAPEUTICS, INC.   |  ALIGOS THERAPEUTICS, INC.
KUSH 
 
PARMAR 
DIRECTOR, EXECUTIVE OFFICER
ARVINAS, INC.   |  SCPHARMACEUTICALS INC.   |  AUDENTES THERAPEUTICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  HOMOLOGY MEDICINES, INC.   |  5AM VENTURES V, L.P.   |  CYCLOPORTERS, INC.   |  AKOUOS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  ARVINAS, INC.   |  RALLYBIO HOLDINGS, LLC   |  VOR BIOPHARMA INC.   |  ENSOMA, INC.
KUSH 
M. 
PARMAR 
DIRECTOR
ENTRADA THERAPEUTICS, INC.   |  RALLYBIO CORP   |  5AM OPPORTUNITIES, L.P.   |  5AM OPPORTUNITIES OFFSHORE, L.P.
DEHUA 
 
PEI 
DIRECTOR
CYCLOPORTERS, INC.   |  ENTRADA THERAPEUTICS, INC.
MARIO 
 
SALTARELLI 
EXECUTIVE OFFICER
ENTRADA THERAPEUTICS, INC.   |  BIOASIS TECHNOLOGIES INC.   |  GABA THERAPEUTICS, INC.
NATARAJAN 
 
SETHURAMAN 
EXECUTIVE OFFICER
ENTRADA THERAPEUTICS, INC.
LOUIS 
 
TARTAGLIA 
DIRECTOR, EXECUTIVE OFFICER
ZAFGEN, INC.   |  EMBER THERAPEUTICS, INC.   |  SOLSTICE BIOLOGICS LLC   |  CYCLOPORTERS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  CURE VENTURES FUND I, L.P.
KORY 
 
WENTWORTH 
EXECUTIVE OFFICER
ENTRADA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-04-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-29 
2019-12-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-14 
2018-12-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-14 
2016-11-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#